XNASCEROW
Market cap23mUSD
Jan 08, Last price
0.02USD
1D
-1.02%
1Q
225.00%
IPO
-61.00%
Name
Phoenix Biotech Acquisition Corp
Chart & Performance
P/E
—
P/S
0.48
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
255k
Net income
-668k
L+111.61%
CFO
-1m
L+56.68%
Profile
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, California.
IPO date
Oct 06, 2021
Employees
Domiciled in
US
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY |
|---|---|---|
| 2022‑12 | 2021‑12 | |
| Income | ||
Revenues | 255 | |
Cost of revenue | 2,841 | |
Unusual Expense (Income) | ||
NOPBT | (2,587) | |
NOPBT Margin | ||
Operating Taxes | 599 | |
Tax Rate | ||
NOPAT | (3,186) | |
Net income | (668) 111.61% | |
Dividends | ||
Dividend yield | ||
Proceeds from repurchase of equity | (139,354) | |
BB yield | 75.82% | |
| Debt | ||
Debt current | 650 | |
Long-term debt | ||
Deferred revenue | ||
Other long-term liabilities | 9,150 | |
Net debt | 174 | |
| Cash flow | ||
Cash from operating activities | (1,092) | |
CAPEX | ||
Cash from investing activities | 180,839 | |
Cash from financing activities | (138,704) | |
FCF | 26,376 | |
| Balance | ||
Cash | 476 | |
Long term investments | ||
Excess cash | 463 | |
Stockholders' equity | 15,693 | |
Invested Capital | 11,206 | |
ROIC | ||
ROCE | ||
| EV | ||
Common stock shares outstanding | 17,896 | |
Price | 10.27 3.64% | |
Market cap | 183,802 -19.29% | |
EV | 183,976 | |
EBITDA | (2,587) | |
EV/EBITDA | ||
Interest | ||
Interest/NOPBT | ||